CKD (6407.T) Stock Price

CKD Price

JPX·CLOSED
5,100.00
+30.00 (+0.59 %)
Market closed

Revenue has compounded at 2.2% per year over the past 19 years to 157.89 B JPY. Earnings per share have grown at 3.1% per year over the last 19 years. CKD's net margin stands at 8.6%, broadly stable from 8.8% several years earlier. CKD currently offers a dividend yield of about 2.14%. The payout ratio is around 40% of earnings. The dividend has grown at 8.1% per year over the past 19 years. Analysts set a median price target of 3,162.00 JPY, implying 38.0% below the current price. Of 15 analysts, 9 rate the stock a buy — an overall Buy consensus. The stock trades about 107% above its 52-week low.

CKD stock price

Volume
Ex-Dividend
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of CKD over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how CKD stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing CKD's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

CKD Stock Price History
DateCKD Price
9/18/20265,100.00 JPY
9/17/20264,910.00 JPY
9/16/20264,970.00 JPY
9/15/20265,040.00 JPY
9/14/20264,910.00 JPY
9/11/20265,080.00 JPY
9/10/20265,150.00 JPY
9/9/20265,310.00 JPY
9/8/20265,050.00 JPY
9/7/20265,430.00 JPY
9/4/20265,190.00 JPY
9/3/20265,180.00 JPY
9/2/20265,120.00 JPY
9/1/20265,300.00 JPY
8/31/20265,450.00 JPY
8/28/20265,570.00 JPY
8/27/20265,490.00 JPY
8/26/20265,560.00 JPY
8/25/20265,510.00 JPY
8/24/20265,550.00 JPY
8/21/20265,570.00 JPY
8/20/20265,630.00 JPY
8/19/20265,610.00 JPY
8/18/20265,860.00 JPY
8/17/20266,170.00 JPY
8/14/20266,150.00 JPY
8/13/20266,310.00 JPY
8/12/20265,890.00 JPY
8/10/20266,420.00 JPY
8/7/20266,330.00 JPY
Access this data via the Eulerpool API

CKD Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
134.43 B JPY
13.11 B JPY
8.34 B JPY
Jan 1, 2025
155.63 B JPY
19.46 B JPY
13.52 B JPY
Jan 1, 2026
157.89 B JPY
21.00 B JPY
13.58 B JPY
Jan 1, 2027 (e)
200.12 B JPY
32.47 B JPY
21.94 B JPY
Jan 1, 2028 (e)
223.24 B JPY
34.38 B JPY
26.08 B JPY
Jan 1, 2029 (e)
230.75 B JPY
37.54 B JPY
27.79 B JPY
Jan 1, 2030 (e)
225.65 B JPY
39.98 B JPY
27.18 B JPY
Jan 1, 2031 (e)
240.05 B JPY
45.39 B JPY
30.91 B JPY

CKD Income Statement, Balance Sheet, Cash Flow Statement

Last updated Sep 21, 2026, 7:50 AM
 
REVENUEB JPY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB JPY
EBITB JPY
EBIT MARGIN%
NET INCOMEB JPY
NET INCOME GROWTH%
DIV.JPY
DIV. GROWTH%
SHARESM
201620172018201920202021202220232024202520262027e2028e2029e2030e2031e
88.1294.01115.70115.67100.72106.72142.20159.46134.43155.63157.89200.12223.24230.75225.65240.05
5.686.6923.07-0.03-12.925.9633.2412.14-15.7015.781.4526.7511.563.36-2.216.38
29.8430.1730.5824.1725.1826.2728.1928.5227.5528.3828.9728.9728.9728.9728.9728.97
26.3028.3635.3927.9625.3628.0440.0945.4837.0444.1745.7457.9764.6766.8465.3769.54
8.119.5812.475.425.237.7018.0921.4113.1119.4621.0032.4734.3837.5439.9845.39
9.2010.1910.784.695.197.2112.7213.439.7612.5013.3016.2215.4016.2717.7218.91
5.466.969.144.793.695.2712.5714.798.3413.5213.5821.9426.0827.7927.1830.91
-9.1727.4631.39-47.56-23.0342.93138.3017.66-43.6262.150.4361.5918.866.54-2.1813.70
27.0033.0040.0013.0021.0045.0081.0071.0064.0074.00109.00130.80156.96188.35
3.8522.2221.21-67.5061.54114.2980.00-12.35-9.8615.6347.3020.0020.0020.00
61.9261.9261.9261.9366.6066.6466.6966.7466.7766.8266.8366.8366.8366.8366.8366.83
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales CKD generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue CKD retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare CKD's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares CKD has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against CKD's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

CKD stock margins

The CKD margin analysis displays the gross margin, EBIT margin, as well as the profit margin of CKD. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for CKD.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
28.19 %
12.72 %
8.84 %
Jan 1, 2023
28.52 %
13.43 %
9.27 %
Jan 1, 2024
27.55 %
9.76 %
6.20 %
Jan 1, 2025
28.38 %
12.50 %
8.69 %
Jan 1, 2026
28.97 %
13.30 %
8.60 %
Jan 1, 2027 (e)
28.97 %
16.22 %
10.96 %
Jan 1, 2028 (e)
28.97 %
15.40 %
11.68 %
Jan 1, 2029 (e)
28.97 %
16.27 %
12.04 %

CKD Stock Revenue, EBIT, Earnings per Share

The CKD earnings per share therefore indicates how much revenue CKD has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2022
2,132.19 JPY
271.23 JPY
188.45 JPY
Jan 1, 2023
2,389.32 JPY
320.78 JPY
221.58 JPY
Jan 1, 2024
2,013.16 JPY
196.40 JPY
124.87 JPY
Jan 1, 2025
2,329.22 JPY
291.19 JPY
202.34 JPY
Jan 1, 2026
2,362.36 JPY
314.26 JPY
203.16 JPY
Jan 1, 2027 (e)
2,946.83 JPY
485.81 JPY
323.10 JPY
Jan 1, 2028 (e)
3,287.34 JPY
514.39 JPY
384.04 JPY
Jan 1, 2029 (e)
3,397.88 JPY
561.76 JPY
409.16 JPY

CKD business model & stock analysis

The CKD Corporation is a Japanese company based in Kitakyushu, Japan. It was founded in 1943 and has since grown into a globally operating corporation in the fields of automation technology, mechanical engineering, and products for industrial applications. CKD has a long history of manufacturing products for the automation industry, starting with components for pneumatic systems and expanding to include hydraulic, electric, and electronic products. The company offers a wide range of products and solutions for automation tasks, including sensors, control systems, drives, and valves. CKD operates in various industries, including automotive, electronics, mechanical engineering, and aviation, with subsidiaries in countries such as the USA, China, Taiwan, Singapore, Malaysia, and Thailand. Important business areas for CKD include the production of pneumatic components, systems, and equipment, as well as semiconductor manufacturing machines. The company also produces systems for use in airplanes, such as pressure regulators. In summary, CKD Corporation is a globally operating company with a wide range of products and a strong presence in various industries. It specializes in automation technology and provides products and solutions for industrial applications, particularly in the areas of pneumatics, semiconductor manufacturing, and aviation. CKD holds a strong position in all of these industries and is an important supplier of products and systems.

CKD SWOT Analysis

Strengths

CKD Corp has a strong brand reputation in the industry, with a long-standing history and a large customer base. The company consistently delivers high-quality products and services to its clients, which has contributed to its success. CKD Corp also boasts a highly skilled and experienced workforce, enabling them to provide innovative solutions and stay ahead of the competition. Moreover, the company has a well-established distribution network, ensuring wide market coverage and easy access to customers.

Weaknesses

One of the main weaknesses of CKD Corp is its heavy reliance on a few key customers for a significant portion of its revenue. This dependency poses a risk to the company's financial stability, especially in cases where these customers may reduce their orders or switch to competitors. Additionally, CKD Corp may face challenges in adapting to rapidly changing market trends and technologies, potentially impacting its ability to stay competitive in the long run.

Opportunities

There are several opportunities that CKD Corp can explore to drive growth and expand its market presence. The increasing global demand for its products and services offers the company an opportunity to enter new markets and reach a wider customer base. CKD Corp can also leverage emerging technologies, such as automation and artificial intelligence, to enhance its product offerings and improve operational efficiency. Moreover, strategic partnerships or acquisitions could provide access to complementary capabilities or new markets, further strengthening CKD Corp's position.

Threats

CKD Corp is exposed to various external threats that could impact its business operations. Intense competition within the industry, both from established players and emerging startups, poses a threat to CKD Corp's market share and profitability. Economic downturns or fluctuations in the global economy could also lead to a decrease in demand for CKD Corp's products, affecting its revenue. Finally, changing government regulations and policies, particularly regarding trade or environmental standards, could require CKD Corp to make significant adaptations to its operations.

CKD Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

CKD historical P/E ratio, EBIT multiple, and P/S ratio

CKD annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down CKD's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in CKD's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare CKD's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

CKD shares outstanding

The number of shares of CKD was 66.82 M in 2025. This indicates how many shares CKD is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2022
66.69 M Stocks
Jan 1, 2023
66.74 M Stocks
Jan 1, 2024
66.77 M Stocks
Jan 1, 2025
66.82 M Stocks
Jan 1, 2026
66.83 M Stocks
Jan 1, 2027 (e)
66.83 M Stocks
Jan 1, 2028 (e)
66.83 M Stocks
Jan 1, 2029 (e)
66.83 M Stocks

CKD Dividend History

37 years of dividend payments

YearAnnual DividendYoY ChangePayments
202635.00JPYYTD
Mar 30, 202635.00JPY 9.4%1/1
202574.00JPY 15.6%
Mar 28, 202542.00JPY 10.5%1/2
Sep 29, 202532.00JPY 23.8%2/2
202464.00JPY 9.9%
202371.00JPY 12.3%
202281.00JPY 80.0%
202145.00JPY 114.3%
202021.00JPY 61.5%
201913.00JPY 67.5%
201840.00JPY 21.2%
201733.00JPY 22.2%

CKD dividend history and estimates

In 2025, CKD paid a dividend amounting to 74.00 JPY. Dividend means that CKD distributes a portion of its profits to its owners.
  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2022
81.00 JPY
0.00 JPY
Jan 1, 2023
71.00 JPY
0.00 JPY
Jan 1, 2024
64.00 JPY
0.00 JPY
Jan 1, 2025
74.00 JPY
0.00 JPY
Jan 1, 2026
109.00 JPY
0.00 JPY
Jan 1, 2027 (e)
0.00 JPY
130.80 JPY
Jan 1, 2028 (e)
0.00 JPY
156.96 JPY
Jan 1, 2029 (e)
0.00 JPY
188.35 JPY

CKD dividend payout ratio

In 2025, CKD had a payout ratio of 36.57%. The payout ratio indicates the percentage of the company's profits that CKD distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2022
42.98 %
Jan 1, 2023
32.04 %
Jan 1, 2024
51.25 %
Jan 1, 2025
36.57 %
Jan 1, 2026
39.96 %
Jan 1, 2027 (e)
40.48 %
Jan 1, 2028 (e)
40.87 %
Jan 1, 2029 (e)
46.03 %

Current CKD forecasts and price targets in September 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
60.00 % (9)
Hold
33.33 % (5)
Sell
6.67 % (1)
12M Price Target
3,162.00
Last Price
5,100.00
Currency
JPY
12M Return Potential
-38.00 %
LTM Return
87.16 %

CKD Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
11/6/202674.07JPY-49.39 BJPY-2026 Q3
8/10/202666.01JPY85.09JPY44.79 BJPY-2026 Q2
5/15/202654.44JPY70.95JPY43.09 BJPY-2026 Q1
2/13/202643.01JPY51.80JPY38.03 BJPY-2025 Q4
11/14/202542.64JPY43.39JPY37.13 BJPY-2025 Q3
8/8/202541.82JPY37.09JPY36.93 BJPY-2025 Q2
2/14/202547.77JPY46.95JPY37.43 BJPY-2024 Q4
11/12/202448.00JPY49.09JPY36.53 BJPY-2024 Q3
8/9/202430.00JPY45.87JPY34.67 BJPY-2024 Q2
5/10/202434.05JPY29.35JPY34.14 BJPY-2024 Q1

CKD shareholder structure

% Name
7.72257%
Nomura Asset Management Co., Ltd.
Nomura Asset Management Co., Ltd.
5.29318%
Sumitomo Mitsui DS Asset Management Company, Limited
Sumitomo Mitsui DS Asset Management Company, Limited
2.50675%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
2.10661%
Nikko Asset Management Co., Ltd.
Nikko Asset Management Co., Ltd.
1.91135%
Sumitomo Mitsui Trust Asset Management Co., Ltd.
Sumitomo Mitsui Trust Asset Management Co., Ltd.
1.88670%
Sumitomo Mitsui Banking Corp
Sumitomo Mitsui Banking Corp

CKD Beneficial Ownership Filings (SEC 13D/G)

Free Float
75.7%
Float Shares
50.62 M
Shares Outstanding
66.84 M

CKD Executives and Management Board

15 members · avg. age 60 · 7 % women

Management

KO

Mr. Katsuhito Okuoka (56)

President, Chief Executive Officer, Representative Director · since 2015

KN

Mr. Katsuhiro Niidera

Managing Executive Officer, Chief Director of Equipment Business, Senior Manager of BU Fine System in Main Equipment Business Unit

MN

Mr. Mamoru Nakatani

Executive Officer, Senior Director of Sales in Main Automatic Machinery Business Unit

YA

Mr. Yoshiyuki Amano (61)

Executive Officer, Director of Digital Strategy, Director · since 2020

SH

Mr. Seichi Hamaguchi

Executive Officer

SK

Mr. Satoru Kawaguchi

Executive Officer

Board of Directors

KK

Mr. Kazunori Kajimoto (67)

Chairman of the Board, Chairman of Board of Directors · since 2004

KH

Mr. Koichi Hayashi (59)

Independent Director

SS

Mr. Stefan Sacre (61)

Independent Director

HS

Ms. Hiroko Shimada (60)

Independent Director

TT

Mr. Tadashi Takezawa

Director of Accounting · since 2020

CKD Supply Chain

CKD Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
13 companies
#Nameβ 1YTrend
1
JPMorgan Chase
Supplier·Customer·Banks·US
0.16
0.56
0.86
0.92
0.77
0.71
0.21
2
Toyota Tsusho
Customer·Trading Companies & Distributors·JP
0.93
0.74
0.67
0.78
0.54
0.60
0.32
3
MISUMI Group
Customer·Machinery·JP
0.76
0.97
0.66
0.89
0.56
0.50
0.38
4
Di-Nikko Engineering
Customer·Electronic Equipment, Instruments & Components·JP
-0.08
0.18
0.06
0.42
0.67
0.45
5
Aval Data
Supplier·Semiconductors & Semiconductor Equipment·JP
0.63
0.87
-0.36
-0.43
0.44
0.44
#Nameβ 1YTrend
1
Nadex
Customer·Machinery·JP
0.65
0.78
0.83
0.91
0.53
2
Tomita
Customer·Trading Companies & Distributors·JP
0.52
-0.15
0.74
0.47
0.24
3
Satori Electric
Customer·Electronic Equipment, Instruments & Components·JP
-0.33
-0.55
-0.56
-0.05
-0.39
-0.17
4
Mitachi
Customer·Electronic Equipment, Instruments & Components·JP
0.72
0.69
0.28
0.52
-0.25
0.15
5
Mitsubishi UFJ Financial Group
Supplier·Customer·Banks·JP
0.82
-0.02
-0.02
-0.77
-0.71
0.22
-0.33

Frequently asked questions about CKD

The business model of CKD Corp is centered around the manufacturing and sale of automation and control systems, as well as industrial machinery and equipment. With a focus on precision and quality, CKD Corp caters to a wide range of industries such as automotive, electronics, and food processing. A key aspect of their business strategy involves developing innovative solutions that enhance productivity and efficiency for their clients. By offering a comprehensive portfolio of products, CKD Corp strives to meet the specific needs of various sectors, steadily growing their presence in the global market.

CKD Corp is primarily active in the industries of manufacturing and engineering. They specialize in developing and producing a wide range of products including industrial automation equipment, pneumatic components, fluid control systems, and environmental products. CKD Corp's expertise and solutions cater to various sectors such as automotive, semiconductor, pharmaceutical, food processing, and packaging. With their strong presence and innovative solutions, CKD Corp has established itself as a leading player in the manufacturing and engineering industries, providing high-quality products and services to their clients worldwide.

The main competitors of CKD Corp in the market include companies like Hitachi Ltd, Keyence Corporation, and SMC Corporation. These companies compete with CKD Corp in the field of manufacturing and supplying industrial automation and control systems, pneumatic equipment, and various related products. With its strong presence and reputation in the market, CKD Corp faces stiff competition from these industry leaders to maintain its market share and meet customer demands.

CKD Corp, founded in 1943, is a leading Japanese company in the manufacturing and distribution of automation technology and equipment. With a rich history spanning over 75 years, CKD Corp has been a pioneer in developing innovative solutions to meet the evolving needs of various industries. The company excels in producing pneumatic components, control equipment, and fluid control systems, serving sectors such as automotive, electronics, and food processing. CKD Corp's commitment to quality, reliability, and customer satisfaction has enabled them to establish a strong presence in both domestic and international markets. Continuously adapting to technological advancements, CKD Corp remains at the forefront of the industry, delivering cutting-edge products and solutions.

Since its inception, CKD Corp has consistently achieved various significant milestones in its journey. Over the years, the company has successfully expanded its product range and strengthened its market presence. Noteworthy achievements include the introduction of innovative technologies, development of cutting-edge solutions, and strategic partnerships with key industry players. Additionally, CKD Corp has demonstrated exceptional growth in revenues and market share. Through its unwavering commitment to excellence and continuous improvement, CKD Corp has solidified its position as a leader in the industry.

CKD Corp is primarily present in Japan and Asia.

CKD Corp is a renowned company representing strong values and a clear corporate philosophy. With a commitment to excellence, innovation, and customer satisfaction, CKD Corp believes in delivering high-quality products and services. The company emphasizes integrity, partnership, and sustainability in every aspect of its operations. CKD Corp strives to create long-term value for its stakeholders while fostering a culture of inclusivity and diversity. By prioritizing customer-centricity and fostering continuous improvement, CKD Corp establishes itself as a trusted and forward-thinking leader in the industry.

Analysts currently set an average price target of 3,385.47 JPY for the CKD stock (median: 3,162.00 JPY), implying -33.2 % versus the latest price. The consensus is based on 15 analyst ratings.

15 analysts currently rate the CKD stock: 9 recommend buying, 5 holding and 1 selling.

Converted at the current exchange rate, the CKD share trades at 28.29 EUR (5,100.00 JPY).

The CKD share (6407.T) is listed on 1 stock exchanges, including: Tokio (JPX) (6407.T).

CKD Corporation is a Japanese company that has been active in the field of machinery and automation since 1943 and is now active in various industries. The name CKD stands for "Central Glass Company Kogyo Division," as the company was initially a division of Central Glass Company. Over the years, the company has become a leading provider of components, systems, and services for the automation industry. CKD's business activities include various sectors, including fluid control systems, electromagnetic valves, and pneumatics. Fluid control systems include valves, pumps, and equipment for controlling liquids and gases in various industrial applications such as food and beverage production, chemical and pharmaceutical industries, and water treatment. Electromagnetic valves provide solutions for controlling gases and liquids and are used in the automotive industry, paper and printing industries, as well as in the production of semiconductors and flat panel displays. Pneumatic products such as cylinders, valves, air pressure pumps, and filtration systems are used in various industries, from the automotive industry to aerospace. The company also offers a range of automation systems and services. These include robots, industrial robot cells, controls, and software for automating processes and equipment in manufacturing industries. CKD also offers a wide range of products for monitoring, controlling, and regulating various parameters in the industry. These include pressure sensors, temperature sensors, flow meters, and humidity sensors. The company operates globally and has branches in Europe, North America, and Asia. CKD also has an extensive research and development department focused on the development of new technologies and products. CKD's business model is based on a consistent focus on the needs of its customers. The company is committed to developing innovative products and solutions that enable its customers to increase productivity, reduce costs, and improve their competitive position. CKD's success is based on a strong culture of innovation, high quality products, and excellent customer support. The company places special emphasis on training its employees and collaborating with its partners and suppliers. In summary, CKD is a leading provider of components, systems, and services for the automation industry. The company offers a wide range of products and solutions in the areas of fluid control systems, electromagnetic valves, pneumatics, automation, monitoring, control and regulation, as well as research and development, enabling its customers to increase productivity and improve their competitive position.

The revenue of CKD is 157.89 B JPY. This figure is based on current financial data and reflects the company's business performance.

The profit of CKD is 13.58 B JPY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of CKD is currently 25.10. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the CKD stock.

The price-to-sales ratio (P/S) of CKD is currently 2.16. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the CKD stock.

The Eulerpool Quality Score for CKD is 5/10.

The ISIN of CKD is JP3346800000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of CKD is 6407.T. The ticker symbol is used to trade CKD shares on the stock exchange.

Over the past 12 months, CKD paid a dividend of 109.00 JPY . This corresponds to a dividend yield of about 2.14 %. For the coming 12 months, CKD is expected to pay a dividend of 130.80 JPY.

The current dividend yield of CKD is 2.14 %.

CKD pays a dividend, distributed in the months of September, March.

CKD paid dividends every year for the past 36 years.

For the upcoming 12 months, dividends amounting to 130.80 JPY are expected. This corresponds to a dividend yield of 2.58 %.

CKD is assigned to the 'Industry' sector.

To receive the latest dividend of CKD from 6/1/2026 amounting to 35 JPY, you needed to have the stock in your portfolio before the ex-date on 3/30/2026.

The last dividend was paid out on 6/1/2026.

In the year 2025, CKD distributed 74 JPY as dividends.

The dividends of CKD are distributed in JPY.

Fair ValuePRO
4,613.70 JPY
Over-/UndervaluationPRO
Fairly valued
Sector
Industry
Machinery
Number of shares
Employees
Revenue per Employee
33.88 M JPY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website ckd.co.jp
Country
Currency
JPY
Initial public offering
Oct 1, 1962
ISIN
JP3346800000
Cusip
J08022113
Sedol
6160050
Market capitalization
344.30 B JPYMega Cap
52-Week Range
2,464.008,180.00JPY
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
3.52
P/E ratio
P/Ee 2027
15.69
P/Ee 2028
13.20
P/Ee 2029
12.39
P/Ee 2030
12.67
P/Ee 2031
11.14
P/S
P/Se
1.69
EV/EBIT
16.00
P/B Ratio
2.24
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
7.22 %
Gross Margin
28.97 %
EBIT Margin
13.30 %
Net Margin
8.60 %
EPS (Earnings Per Share)
203.16 JPY
Net Debt / EBIT
-0.39
Debt/Equity
0.23
Dividend
Dividend yield
2.15 %
Est. Dividend Yield
2.58 %
Payout Ratio
39.96 %
Dividend growth Ø5Y
6.12 %
Dividend payments per year
2
Dividend paid since
36 years
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
15.32 %
Last updated Sep 21, 2026, 7:50 AM

CKD Peer Group

CKD Ticker

JPX · 6407.T

CKD FIGI

6407:JP · BBG000BBRG256407:JT · BBG000BBRGJ76407:JN · BBG000BBRGR86407:JJ · BBG000BBRMP76407:JE · BBG000BBRPJ76407:JI · BBG000BBRPQ96407:JU · BBG002QK5YY56407:JW · BBG00875BBC36407JPY:X2 · BBG00K60V1386407JPY:XB · BBG00K60V1476407JPY:XH · BBG00K60V1656407JPY:XF · BBG00K60V183

All fundamentals and in-depth analysis of CKD

Our stock analysis for CKD stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CKD. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.